Clinical trials
Completed Endocrine System Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| AstraZeneca | 1 |
| Chaohu Hospital of Anhui Medical University | 1 |
| Hoffmann-La Roche | 1 |
| Huashan Hospital | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| Sun Yat-sen University | 1 |
| The Hong Kong Polytechnic University | 1 |
| Visen Pharmaceuticals (Shanghai) Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 11 |
| Metabolic Diseases | 4 |
| Diabetes Mellitus | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Digestive System Diseases | 3 |
| Glucose Metabolism Disorders | 3 |
| Immune System Diseases | 3 |
| Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Autoimmune Diseases | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.